Translation and validation of the Chinese version of the MD Anderson symptom inventory for measuring perioperative symptom burden in patients with gynecologic cancer.
机构:[1]Gynecological Oncology Department of Sichuan Cancer Hospital and Institute,Sichuan Cancer Center, School of Medicine, University of Electronic Scienceand Technology of China, Chengdu, China四川省肿瘤医院[2]School of Nursing, ChengduUniversity of Traditional Chinese Medicine, Chengdu, China[3]Nursing Study Center, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Schoolof Medicine, University of Electronic Science and Technology of China, No.55, 4Th Section of Renmin South Road, Chengdu, Sichuan, China四川省肿瘤医院[4]Schoolof Public Health and Management, Chongqing Medical University, Chongqing,China[5]Hospital Infection Department of Sichuan Cancer Hospital and Institute,Sichuan Cancer Center, School of Medicine, University of ElectronicScience and Technology of China, Chengdu, China四川省肿瘤医院[6]Department of SymptomResearch, The University of Texas MD Anderson Cancer Center, Houston, TX,USA
第一作者机构:[1]Gynecological Oncology Department of Sichuan Cancer Hospital and Institute,Sichuan Cancer Center, School of Medicine, University of Electronic Scienceand Technology of China, Chengdu, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Zhang Ting,Zheng Ying-Ying,Yang Zhi-Rong,et al.Translation and validation of the Chinese version of the MD Anderson symptom inventory for measuring perioperative symptom burden in patients with gynecologic cancer.[J].BMC WOMENS HEALTH.2021,21(1):doi:10.1186/s12905-021-01415-0.
APA:
Zhang Ting,Zheng Ying-Ying,Yang Zhi-Rong,Shi Qiuling,Wang Xin Shelley...&Wang Guo-Rong.(2021).Translation and validation of the Chinese version of the MD Anderson symptom inventory for measuring perioperative symptom burden in patients with gynecologic cancer..BMC WOMENS HEALTH,21,(1)
MLA:
Zhang Ting,et al."Translation and validation of the Chinese version of the MD Anderson symptom inventory for measuring perioperative symptom burden in patients with gynecologic cancer.".BMC WOMENS HEALTH 21..1(2021)